What are the ultrasound criteria for evaluating lymph nodes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ultrasound Criteria for Evaluating Lymph Nodes

When evaluating lymph nodes by ultrasound, systematically assess seven key features: size, shape, echogenicity, presence of hilum, microcalcifications, cystic changes, and vascular pattern using both B-mode and Doppler imaging. 1, 2

Major Criteria Highly Suspicious for Malignancy

The following four features are independently predictive of malignancy and warrant immediate biopsy when present 1, 2:

  • Microcalcifications (hyperechoic punctuations) - 46% sensitivity, 100% specificity 3
  • Cystic appearance or necrotic zones - 11% sensitivity, 100% specificity 3
  • Peripheral and/or mixed peripheral vascularization on Doppler - 86% sensitivity, 82% specificity (best sensitivity-specificity balance) 3
  • Hyperechoic lymph node resembling thyroid tissue (specific to thyroid metastases) 2

Any single major criterion is sufficient to recommend fine needle aspiration biopsy 2.

Secondary Criteria (Combined Assessment Required)

These features are less discriminating individually but raise suspicion when combined 1, 2:

  • Short axis ≥ 8 mm (sensitivity 42-61%, specificity 87-96%) 2
  • Round shape with L/S ratio < 2 (sensitivity 46-95%, specificity 64-95%) 2
  • Loss of fatty hyperechoic hilum (sensitivity 100%, but specificity only 29%) 3

When all three secondary criteria are present together, consider biopsy based on clinical context 2.

Benign Features (No Biopsy Needed)

Lymph nodes are highly likely benign when 2, 3:

  • Visible hyperechoic hilum present
  • Central hilar vascularization only (no peripheral flow)
  • Absence of all four major suspicious criteria
  • Oval/spindle shape (L/S ratio ≥ 2)

A visible hyperechoic hilum has 100% specificity for benignity - no malignant nodes showed this feature in validation studies 3.

Size Thresholds and Clinical Context

The evidence on size is conflicting 1. While 95-100% of benign nodes have short axis < 8 mm, size alone is unreliable 2:

  • For nodes < 5-7 mm: Do not routinely biopsy unless ≥2 ultrasound criteria for malignancy are present 2
  • For nodes ≥ 8 mm: Size becomes more relevant when combined with other features
  • Larger nodes (>2 cm) show statistically higher malignancy rates 1

Vascular Pattern Classification

Using power/color Doppler, assess blood flow patterns 1:

  • Grade 0-1 (no flow or single central vessel): Benign pattern
  • Grade 2-3 (rich flow with >4 vessels): Malignant pattern (sensitivity 87.7%, specificity 69.6%)

Common Pitfalls to Avoid

Hypoechogenicity alone is not discriminating - over 90% of benign nodes are hypoechoic, and this feature has only 39% sensitivity and 18% specificity for malignancy 2. Do not use this as a standalone criterion.

Loss of hilum as a single criterion is insufficient - while 100% sensitive, it has only 29% specificity since many normal nodes lack visible hilum 3. Always combine with other features.

Small nodes can be malignant - normal lymph nodes <8 mm are often round without visible hilum, making morphologic assessment challenging 2. Use clinical context (tumor burden, serum markers) to guide decision-making.

Algorithmic Approach

  1. First: Look for any of the four major criteria (microcalcifications, cystic changes, peripheral vascularity, hyperechoic appearance)

    • If present → Recommend biopsy
  2. Second: If no major criteria, assess for benign features (visible hilum + central vascularity only)

    • If present → No biopsy needed
  3. Third: If indeterminate, evaluate all three secondary criteria together (size ≥8mm + round shape + absent hilum)

    • If all three present → Consider biopsy based on clinical risk factors
    • If <3 present → Follow-up imaging in 6-12 months 2

Critical caveat: Ultrasound features alone cannot replace tissue diagnosis. Even with highly suspicious features, histopathologic confirmation remains mandatory for definitive diagnosis 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.